Kim 2014.

Trial name or title	Self‐blood glucose monitoring and real‐time continuous glucose monitoring in patients with GDM
Methods	Randomised controlled trial
Participants	Women with newly diagnosed GDM who meet 'two‐step' approach (Carpenter and Coustan criteria) at 24‐28 weeks' gestation.
Interventions	Intervention group: as per control group, plus real‐time continuous glucose monitoring Control group: women receive education every 1 to 2 weeks, about glucose controlling and diet, according to their self‐monitored glucose levels.
Outcomes	Primary outcome: composite maternal and neonatal outcome consisting of: pregnancy‐induced pre‐eclampsia; preterm birth; macrosomia/large‐for‐gestational age/small‐for‐gestational age; and obstetric trauma Secondary outcomes: caesarean birth; eclampsia, gestational hypertension; intrauterine fetal death; gestational age at birth; birthweight, birthweight percentile; neonatal hypoglycaemia; hyperbilirubinaemia; respiratory distress syndrome
Starting date	Anticipated date of first enrolment: 29 May 2015
Contact information	Jae Hyeon KIm: jaehyeon@skku.edu Samsung Medical Center, Seoul, South Korea
Notes	Recruitment target: 178 women